The inflammatory role of phagocyte apoptotic pathways in rheumatic diseases

Nature Reviews Rheumatology

Volumn 12, Issue 9, 2016, Pages 543-558

  Cuda, Carla M ^a   Pope, Richard M ^a   Perlman, Harris ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; CHEMOKINE; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR5; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INFLAMMASOME; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TRANSFORMING GROWTH FACTOR BETA; APOPTOSIS REGULATORY PROTEIN; FADD PROTEIN, MOUSE; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS PROTEIN, MOUSE; FLICE INHIBITORY PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 6;

APOPTOSIS; AUTOIMMUNE DISEASE; AUTOPHAGY; CD4+ T LYMPHOCYTE; CELL DEATH; CYTOKINE PRODUCTION; DENDRITIC CELL; ENVIRONMENTAL FACTOR; GENETIC POLYMORPHISM; HEREDITY; HUMAN; IMMUNE SYSTEM; INNATE IMMUNITY; MACROPHAGE; MOUSE; NONHUMAN; PATHOGENESIS; PHAGOCYTE; PHAGOCYTOSIS; POLARIZATION; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; TH17 CELL; ANIMAL; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 8; DENDRITIC CELLS; FAS RECEPTOR; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; HUMANS; MACROPHAGES; PHAGOCYTES; PHAGOCYTOSIS; RHEUMATIC DISEASES; SIGNAL TRANSDUCTION;

EID: 84983436115     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2016.132     Document Type: Review

References (199)

1. Helmick, C. G., et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 58, 15-25 (2008
2. Lundy, S. K., Sarkar, S., Tesmer, L. A., & Fox, D. A. Cells of the synovium in rheumatoid arthritis. T lymphocytes. Arthritis Res. Ther. 9, 202 (2007
3. Geissmann, F., et al. Development of monocytes, macrophages, and dendritic cells. Science 327, 656-661 (2010
4. Farache, J., Zigmond, E., Shakhar, G., & Jung, S. Contributions of dendritic cells and macrophages to intestinal homeostasis and immune defense. Immunol. Cell Biol. 91, 232-239 (2013
5. Galli, S. J., Borregaard, N., & Wynn, T. A. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat. Immunol. 12, 1035-1044 (2011
6. van den Berg, W. B., & van Lent, P. L. E. M. The role of macrophages in chronic arthritis. Immunbiol. 195, 614-623 (1996
7. Ziegler-Heitbrock, L., et al. Nomenclature of monocytes and dendritic cells in blood. Blood 116, e74-80 (2010
8. Mulherin, D., Fitzgerald, O., & Bresnihan, B. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum. 39, 115-124 (1996
9. Yanni, G., Whelan, A., Feighery, C., & Bresnihan, B. Synovial tissue macrophages and joint erosion in rheumatoid arthritis. Ann. Rheum. Dis. 53, 39-44 (1994
10. Choy, E. H., & Panayi, G. S. Cytokine pathways and joint inflammation in rheumatoid arthritis. N. Engl. J. Med. 344, 907-916 (2001
11. Huang, Q., Ma, Y., Adebayo, A., & Pope, R. M. Increased macrophage activation mediated through toll-like receptors in rheumatoid arthritis. Arthritis Rheum. 56, 2192-2201 (2007
12. Chamberlain, N. D., et al. Ligation of TLR7 by rheumatoid arthritis synovial fluid single strand RNA induces transcription of TNFα in monocytes. Ann. Rheum. Dis. 72, 418-426 (2013
13. Huang, Q., & Pope, R. M. Toll-like receptor signaling: a potential link among rheumatoid arthritis, systemic lupus, and atherosclerosis. J. Leukocyte Biol. 88, 253-262 (2010
14. Nuki, G., Bresnihan, B., Bear, M. B., & McCabe, D. Long-Term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin 1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 46, 2838-2846 (2002
15. Genovese, M. C., et al. Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes. Arthritis Rheum. 46, 1443-1450 (2002
16. De Rycke, L., et al. Differential expression and response to anti-TNFα treatment of infiltrating versus resident tissue macrophage subsets in autoimmune arthritis. J. Pathol. 206, 17-27 (2005
17. Bresnihan, B., et al. Synovial macrophages as a biomarker of response to therapeutic intervention in rheumatoid arthritis: standardization and consistency across centers. J. Rheumatol. 34, 620-622 (2007
18. Wijbrandts, C. A., et al. Absence of changes in the number of synovial sublining macrophages after ineffective treatment for rheumatoid arthritis: implications for use of synovial sublining macrophages as a biomarker. Arthritis Rheum. 56, 3869-3871 (2007
19. Arandjelovic, S., & Ravichandran, K. S. Phagocytosis of apoptotic cells in homeostasis. Nat. Immunol. 16, 907-917 (2015
20. Gatza, E., et al. Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells. Blood 112, 1515-1521 (2008
21. Hashimoto, D., Miller, J., & Merad, M. Dendritic cell and macrophage heterogeneity in vivo. Immunity 35, 323-335 (2011
22. Roszer, T. Understanding the mysterious M2 macrophage through activation markers and effector mechanisms. Mediators Inflamm. 2015, 816460 (2015
23. Gordon, S., & Martinez, F. O. Alternative activation of macrophages: mechanism and functions. Immunity 32, 593-604 (2010
24. Odegaard, J. I., & Chawla, A. Alternative macrophage activation and metabolism. Annu. Rev. Pathol. 6, 275-297 (2011
25. Martinez, F. O., & Gordon, S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 6, 13 (2014
26. Murray, P. J., et al. Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines. Immunity 41, 14-20 (2014
27. Xue, J., et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 40, 274-288 (2014
28. van Furth, R., & Cohn, Z. A. The origin and kinetics of mononuclear phagocytes. J. Exp. Med. 128, 415-435 (1968
29. Edwards, J. C., & Willoughby, D. A. Demonstration of bone marrow derived cells in synovial lining by means of giant intracellular granules as genetic markers. Ann. Rheum. Dis. 41, 177-182 (1982
30. Edwards, J. C. The nature and origins of synovium: experimental approaches to the study of synoviocyte differentiation. J. Anat. 184, 493-501 (1994
31. Yona, S., et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 38, 79-91 (2013
32. Schulz, C., et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336, 86-90 (2012
33. Ginhoux, F., et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330, 841-845 (2010
34. Amit, I., Winter, D. R., & Jung, S. The role of the local environment and epigenetics in shaping macrophage identity and their effect on tissue homeostasis. Nat. Immunol. 17, 18-25 (2015
35. Gomez Perdiguero, E., et al. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature 518, 547-551 (2015
36. Gomez Perdiguero, E., et al. The origin of tissue-resident macrophages: when an erythro-myeloid progenitor is an erythro-myeloid progenitor. Immunity 43, 1023-1024 (2015
37. Hoeffel, G., & Ginhoux, F. Ontogeny of tissue-resident macrophages. Front. Immunol. 6, 486 (2015
38. Hoeffel, G., et al C Myb(+) erythro-myeloid progenitor-derived fetal monocytes give rise to adult tissue-resident macrophages. Immunity 42, 665-678 (2015
39. Perdiguero, E. G., & Geissmann, F. The development and maintenance of resident macrophages. Nat. Immunol. 17, 2-8 (2015
40. Varol, C., Mildner, A., & Jung, S. Macrophages: development and tissue specialization. Annu. Rev. Immunol. 33, 643-675 (2015
41. Hashimoto, D., et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity 38, 792-804 (2013
42. Jenkins, S. J., et al. Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science 332, 1284-1288 (2011
43. Davies, L. C., et al. A quantifiable proliferative burst of tissue macrophages restores homeostatic macrophage populations after acute inflammation. Eur. J. Immunol. 41, 2155-2164 (2011
44. Davies, L. C., et al. Distinct bone marrow-derived and tissue-resident macrophage lineages proliferate at key stages during inflammation. Nat. Commun. 4, 1886 (2013
45. Misharin, A. V., et al. Nonclassical Ly6C-monocytes drive the development of inflammatory arthritis in mice. Cell Rep. 9, 591-604 (2014
46. Korns, D., Frasch, S. C., Fernandez-Boyanapalli, R., Henson, P. M., & Bratton, D. L. Modulation of macrophage efferocytosis in inflammation. Front. Immunol. 2, 57 (2011
47. Lebre, M. C., et al. Rheumatoid arthritis synovium contains two subsets of CD83-DC LAMP-dendritic Cells with Distinct Cytokine Profiles. Am. J. Pathol. 172, 940-950 (2008
48. Thomas, R., & Quinn, C. Functional differentiation of dendritic cells in rheumatoid arthritis: role of CD86 in the synovium. J. Immunol. 156, 3074-3086 (1996
49. Summers, K. L., O?Donnell, J. L., Williams, L. A., & Hart, D. N. Expression and function of CD80 and CD86 costimulator molecules on synovial dendritic cells in chronic arthritis. Arthritis Rheum. 39, 1287-1291 (1996
50. Page, G., Lebecque, S., & Miossec, P. Anatomic localization of immature and mature dendritic cells in an ectopic lymphoid organ: correlation with selective chemokine expression in rheumatoid synovium. J. Immunol. 168, 5333-5341 (2002
51. Radstake, T. R., et al. Increased FcγRII expression and aberrant tumour necrosis factor α production by mature dendritic cells from patients with active rheumatoid arthritis. Ann. Rheum. Dis. 63, 1556-1563 (2004
52. Radstake, T. R., et al. Expression of Toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin 12 and interleukin 18 via interferon-γ. Arthritis Rheum. 50, 3856-3865 (2004
53. Ronnblom, L., & Alm, G. V. The natural interferon-α producing cells in systemic lupus erythematosus. Hum. Immunol. 63, 1181-1193 (2002
54. van der Pouw Kraan, T. C., et al. Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients. Ann. Rheum. Dis. 66, 1008-1014 (2007
55. Richez, C., et al. Myeloid dendritic cells correlate with clinical response whereas plasmacytoid dendritic cells impact autoantibody development in rheumatoid arthritis patients treated with infliximab. Arthritis Res. Ther. 11, R100 (2009
56. Thomas, R., Davis, L. S., & Lipsky, P. E. Rheumatoid synovium is enriched in mature antigen-presenting dendritic cells. J. Immunol. 152, 2613-2623 (1994
57. Pettit, A. R., MacDonald, K. P., O?Sullivan, B., & Thomas, R. Differentiated dendritic cells expressing nuclear RelB are predominantly located in rheumatoid synovial tissue perivascular mononuclear cell aggregates. Arthritis Rheum. 43, 791-800 (2000
58. Klareskog, L., Forsum, U., Scheynius, A., Kabelitz, D., & Wigzell, H. Evidence in support of a self-perpetuating HLA DR dependent delayed-Type cell reaction in rheumatoid arthritis. Proc. Natl Acad. Sci. USA 79, 3632-3636 (1982
59. Jongbloed, S. L., et al. Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis. Arthritis Res. Ther. 8, R15 (2006
60. Remijsen, Q., et al. Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality. Cell Death Differ. 18, 581-588 (2011
61. Schauer, C., et al. Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines. Nat. Med. 20, 511-517 (2014
62. Pope, R. M. Apoptosis as a therapeutic tool in rheumatoid arthritis. Nat. Rev. Immunol. 2, 527-535 (2002
63. Korb, A., Pavenstadt, H., & Pap, T. Cell death in rheumatoid arthritis. Apoptosis 14, 447-454 (2009
64. Peter, M. E., et al. The CD95 receptor: apoptosis revisited. Cell 129, 447-450 (2007
65. Green, D. R. Apoptotic pathways: the roads to ruin. Cell 94, 695-698 (1998
66. Boatright, K. M., Deis, C., Denault, J. B., Sutherlin, D. P., & Salvesen, G. S. Activation of caspases 8 and-10 by FLIP(L). Biochem. J. 382, 651-657 (2004
67. Micheau, O., et al. The long form of FLIP is an activator of caspase 8 at the Fas death-inducing signaling complex. J. Biol. Chem. 277, 45162-45171 (2002
68. Luo, X., Budihardjo, I., Zou, H., Slaughter, C., & Wang, X. Bid, a Bcl 2 interacting protein mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94, 481-490 (1998
69. Li, P., et al. Cytochrome c and dATP-dependent formation of Apaf 1/caspase 9 complex initiates an apoptotic protease cascade. Cell 91, 479-489 (1997
70. Wang, K., Yin, X. M., Chao, D. T., Milliman, C. L., & Korsmeyer, S. J. BID, a novel BH3 domain only death agonist. Genes Dev. 10, 2859-2869 (1996
71. Firestein, G. S. Apoptosis in rheumatoid arthritis synovium. J. Clin. Invest. 96, 1631-1638 (1995
72. Nakajima, T., et al. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum. 38, 485-491 (1995
73. Hashmioto, H., et al. Soluble Fas ligand in the joints of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum. 41, 657-662 (1998
74. Pundt, N., et al. Susceptibility of rheumatoid arthritis synovial fibroblasts to FasL-And TRAIL-induced apoptosis is cell cycle-dependent. Arthritis Res. Ther. 11, R16 (2009
75. Cantwell, M. J., Hua, T., Zvaifler, N. J., & Kipps, T. J. Deficient Fas ligand expression by synovial lymphocytes from patients with rheumatoid arthritis. Arthritis Rheum. 40, 1644-1652 (1997
76. Wakisaka, S., et al. Modulation by proinflammatory cytokines of Fas/Fas ligand-mediated apoptotic cell death of synovial cells in patients with rheumatoid arthritis. Clin. Exp. Immunol. 114, 119-128 (1998
77. Kobayashi, T., et al. Differential regulation of Fas-mediated apoptosis of rheumatoid synoviocytes by tumor necrosis factor alpha and basic fibroblast growth factor is associated with the expression of apoptosis-related molecules. Arthritis Rheum. 43, 1106-1114 (2000
78. Salmon, M., et al. Inhibition of T cell apoptosis in the rheumatoid synovium. J. Clin. Invest. 99, 439-446 (1997
79. Migita, K., et al. Nitric oxide protects cultured rheumatoid synovial cells from Fas-induced apoptosis by inhibiting caspase 3. Immunology 103, 362-367 (2001
80. Cohen, P. L., & Eisenberg, R. A. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9, 243-269 (1991
81. Ito, M. R., et al. Rheumatic diseases in an MRL strain of mice with a deficit in the functional Fas ligand. Arthritis Rheum. 40, 1054-1063 (1997
82. Cuda, C. M., et al. Requirement of myeloid cell-specific Fas expression for prevention of systemic autoimmunity in mice. Arthritis Rheum. 64, 808-820 (2012
83. Richez, C., Blanco, P., Rifkin, I., Moreau, J. F., & Schaeverbeke, T. Role for toll-like receptors in autoimmune disease: the example of systemic lupus erythematosus. Joint Bone Spine 78, 124-130 (2010
84. Brown, N. J., et al. Fas death receptor signaling represses monocyte numbers and macrophage activation in vivo. J. Immunol. 173, 7584-7593 (2004
85. Ma Y., et al. Fas ligation on macrophages enhances IL 1R1 Toll-like receptor 4 signaling and promotes chronic inflammation. Nat. Immunol. 380-387 2004
86. Huang, Q. Q., et al. Fas signaling in macrophages promotes chronicity in K/BxN serum-induced arthritis. Arthritis Rheumatol. 66, 68-77 (2014
87. Stranges, P. B., et al. Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity. Immunity 26, 629-641 (2007
88. Kobayashi, T., et al. Novel gene therapy for rheumatoid arthritis by FADD gene transfer: induction of apoptosis of rheumatoid synoviocytes but not chondrocytes. Gene Ther. 7, 527-533 (2000
89. Tourneur, L., Mistou, S., Schmitt, A., & Chiocchia, G. Adenosine receptors control a new pathway of Fas-Associated death domain protein expression regulation by secretion. J. Biol. Chem. 283, 17929-17938 (2008
90. Berckmans, R. J., et al. Synovial microparticles from arthritic patients modulate chemokine and cytokine release by synoviocytes. Arthritis Res. Ther. 7, R536-544 (2005
91. Vilmont, V., Tourneur, L., & Chiocchia, G. Fas-Associated death domain protein and adenosine partnership: fad in RA. Rheumatology (Oxford) 51, 964-975 (2012
92. Schock, S. N., Young, J. A., He, T. H., Sun, Y., & Winoto, A. Deletion of FADD in macrophages and granulocytes results in RIP3-And MyD88 dependent systemic inflammation. PLoS ONE 10, e0124391 (2015
93. Young, J. A., He, T. H., Reizis, B., & Winoto, A. Commensal microbiota are required for systemic inflammation triggered by necrotic dendritic cells. Cell Rep. 3, 1932-1944 (2013
94. Perlman, H., et al. Rheumatoid arthritis synovial macrophages express the Fas-Associated death domain-like interleukin 1β converting enzyme-inhibitory protein and are refractory to Fas-mediated apoptosis. Arthritis Rheum. 44, 21-30 (2001
95. Catrina, A. I., Ulfgren, A. K., Lindblad, S., Grondal, L., & Klareskog, L. Low levels of apoptosis and high FLIP expression in early rheumatoid arthritis synovium. Ann. Rheum. Dis. 61, 934-936 (2002
96. Schedel, J., et al. FLICE-inhibitory protein expression in synovial fibroblasts and at sites of cartilage and bone erosion in rheumatoid arthritis. Arthritis Rheum. 46, 1512-1518 (2002
97. Perlman, H., et al. FLICE-inhibitory protein expression during macrophage differentiation confers resistance to fas-mediated apoptosis. J. Exp. Med. 190, 1679-1688 (1999
98. Huang, Q. Q., et al. FLIP: a novel regulator of macrophage differentiation and granulocyte homeostasis. Blood 116, 4968-4977 (2010
99. Gordy, C., Pua, H., Sempowski, G. D., & He, Y. W. Regulation of steady-state neutrophil homeostasis by macrophages. Blood 117, 618-629 (2011
100. Huang, Q. Q., et al. CD11c mediated deletion of Flip promotes autoreactivity and inflammatory arthritis. Nat. Commun. 6, 7086 (2015
101. Wu, Y. J., et al. Cellular FLIP inhibits myeloid cell activation by suppressing selective innate signaling. J. Immunol. 195, 2612-2623 (2015
102. Kamada, N., & Nunez, G. Regulation of the immune system by the resident intestinal bacteria. Gastroenterology 146, 1477-1488 (2014
103. Kabat, A. M., Srinivasan, N., & Maloy, K. J. Modulation of immune development and function by intestinal microbiota. Trends Immunol. 35, 507-517 (2014
104. Lukens, J. R., et al. Dietary modulation of the microbiome affects autoinflammatory disease. Nature 516, 246-249 (2014
105. Okada, Y., et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506, 376-381 (2014
106. Helfer, B., et al. Caspase 8 promotes cell motility and calpain activity under nonapoptotic conditions. Cancer Res. 66, 4273-4278 (2006
107. Dohrman, A., et al. Cellular FLIP (long form) regulates CD8+ T cell activation through caspase 8 dependent NF kappa B activation. J. Immunol. 174, 5270-5278 (2005
108. Rajput, A., et al. RIG I RNA helicase activation of IRF3 transcription factor is negatively regulated by caspase 8 mediated cleavage of the RIP1 protein. Immunity 34, 340-351(2011
109. Kovalenko, A., et al. Caspase 8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease. J. Exp. Med. 206, 2161-2177 (2009
110. Hu, W. H., Johnson, H., & Shu, H. B. Activation of NF kappaB by FADD, Casper, and caspase 8. J. Biol. Chem. 275, 10838-10844 (2000
111. Sears, N., Sen, G. C., Stark, G. R., & Chattopadhyay, S. Caspase 8 mediated cleavage inhibits IRF 3 protein by facilitating its proteasome-mediated degradation. J. Biol. Chem. 286, 33037-33044 (2011
112. Cuda, C. M., et al. Conditional deletion of caspase 8 in macrophages alters macrophage activation in a RIPK-dependent manner. Arthritis Res. Ther. 17, 291 (2015
113. Kang, T. B., et al. Caspase 8 serves both apoptotic and nonapoptotic roles. J. Immunol. 173, 2976-2984 (2004
114. Cuda, C. M., et al. Caspase 8 acts as a molecular rheostat to limit RIPK1-And MyD88 mediated dendritic cell activation. J. Immunol. 192, 5548-5560 (2014
115. Kang, T. B., Yang, S. H., Toth, B., Kovalenko, A., & Wallach, D. Caspase 8 blocks kinase RIPK3 mediated activation of the NLRP3 inflammasome. Immunity 38, 27-40 (2013
116. Adams, J. M., & Cory, S. The Bcl 2 protein family: arbiters of cell survival. Science 281, 1322-1326 (1998
117. Delbridge, A. R., & Strasser, A. The BCL 2 protein family, BH3 mimetics and cancer therapy. Cell Death Differ. 22, 1071-1080 (2015
118. Opferman, J. T. Attacking cancer?s Achilles heel: antagonism of anti-Apoptotic BCL 2 family members. FEBS J. http://dx.doi.org/10.1111/febs.13472 (2015
119. Perlman, H., et al. Bcl 2 expression in synovial fibroblasts is essential for maintaining mitochondrial homeostasis and cell viability. J. Immunol. 164, 5227-5235 (2000
120. Busteed S., et al. Bcl x(L) expression in vivo in rheumatoid synovium. Clin. Rheumatol 25 789-793 2006
121. Liu, H., et al. Regulation of Mcl 1 expression in rheumatoid arthritis synovial macrophages. Arthritis Rheum. 54, 3174-3181 (2006
122. Liu, H., et al. Mcl 1 is essential for the survival of synovial fibroblasts in rheumatoid arthritis. J. Immunol. 175, 8337-8345 (2005
123. Cha, H. S., Rosengren, S., Boyle, D. L., & Firestein, G. S. PUMA regulation and proapoptotic effects in fibroblast-like synoviocytes. Arthritis Rheum. 54, 587-592 (2006
124. Hilbers, I., et al. Expression of the apoptosis accelerator Bax in rheumatoid arthritis synovium. Rheumatol Int. 23, 75-81 (2003
125. Scatizzi, J. C., et al. Bim-Bcl 2 homology 3 mimetic therapy is effective at suppressing inflammatory arthritis through the activation of myeloid cell apoptosis. Arthritis Rheum. 62, 441-451 (2010
126. Zheng, B., et al. Overexpression of Bcl(XL) in B cells promotes TH1 response and exacerbates collagen-induced arthritis. J. Immunol. 179, 7087-7092 (2007
127. Chen, Y., Rosloniec, E., Price, J., Boothby, M., & Chen, J. Constitutive expression of BCL X(L) in the T lineage attenuates collagen-induced arthritis in Bcl X(L) transgenic mice. Arthritis Rheum. 46, 514-521 (2002
128. Lawlor, K. E., et al. Bcl 2 overexpression ameliorates immune complex-mediated arthritis by altering FcγRIIb expression and monocyte homeostasis. J. Leukocyte Biol. 93, 585-597 (2013
129. Bardwell, P. D., et al. The Bcl 2 family antagonist ABT 737 significantly inhibits multiple animal models of autoimmunity. J. Immunol. 182, 7482-7489 (2009
130. Lawlor, K. E., Smith, S. D., van Nieuwenhuijze, A., Huang, D. C., & Wicks, I. P. Evaluation of the Bcl 2 family antagonist ABT 737 in collagen-induced arthritis. J. Leukocyte Biol. 90, 819-829 (2011
131. Scatizzi, J. C., et al. Bim deficiency leads to exacerbation and prolongation of joint inflammation in experimental arthritis. Arthritis Rheum. 54, 3182-3193 (2006
132. Scatizzi, J. C., et al. Pro-Apoptotic Bid is required for the resolution of the effector phase of inflammatory arthritis. Arthritis Res. Ther. 9, R49 (2007
133. Bouillet, P., et al. Proapoptotic Bcl 2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286, 1735-1738 (1999
134. Hutcheson, J., et al. Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity. Immunity 28, 206-217 (2008
135. Hutcheson, J., & Perlman, H. BH3 only proteins in rheumatoid arthritis: potential targets for therapeutic intervention. Oncogene 27 (Suppl. 1), S168-S175 (2008
136. Egle, A., Harris, A. W., Bath, M. L., O?Reilly, L., & Cory, S. VavP Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia. Blood 103, 2276-2283 (2003). pii] (2004
137. Zhou, P., et al. MCL1 transgenic mice exhibit a high incidence of B cell lymphoma manifested as a spectrum of histologic subtypes. Blood 97, 3902-3909 (2001
138. Zhou, P., et al. Mcl 1 in transgenic mice promotes survival in a spectrum of hematopoietic cell types and immortalization in the myeloid lineage. Blood 92, 3226-3239 (1998
139. Chen, M., Huang, L., & Wang, J. Deficiency of Bim in dendritic cells contributes to over-Activation of lymphocytes and autoimmunity. Blood 109, 4360-4367 (2007
140. Gautier, E. L., et al. Enhanced dendritic cell survival attenuates lipopolysaccharide-induced immunosuppression and increases resistance to lethal endotoxic shock. J. Immunol. 180, 6941-6946 (2008
141. Nopora, A., & Brocker, T. Bcl 2 controls dendritic cell longevity in vivo. J. Immunol. 169, 3006-3014 (2002
142. Hou, W. S., & Van Parijs, L. A. Bcl 2 dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells. Nat. Immunol. 5, 583-589 (2004
143. Yeretssian, G., et al. Non-Apoptotic role of BID in inflammation and innate immunity. Nature 474, 96-99 (2011
144. Pasparakis, M., & Vandenabeele, P. Necroptosis and its role in inflammation. Nature 517, 311-320 (2015
145. Oberst, A., et al. Catalytic activity of the caspase 8 FLIP(L) complex inhibits RIPK3 dependent necrosis. Nature 471, 363-367 (2011
146. Feoktistova, M., et al. cIAPs block Ripoptosome formation, a RIP1/caspase 8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol. Cell 43, 449-463 (2011
147. Vince, J. E., et al. Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin 1 activation. Immunity 36, 215-227 (2012
148. Gurung, P., et al. FADD and Caspase 8 Mediate Priming and Activation of the Canonical and Noncanonical Nlrp3 Inflammasomes. J. Immunol. 192, 1835-1846 (2014
149. Shenderov, K., et al. Cutting edge: endoplasmic reticulum stress licenses macrophages to produce mature IL 1β in response to TLR4 stimulation through a caspase 8-And TRIF-dependent pathway. J. Immunol. 192, 2029-2033 (2014
150. Zhang, H., et al. Functional complementation between FADD and RIP1 in embryos and lymphocytes. Nature 471, 373-376 (2011
151. Newton, K., Sun, X., & Dixit, V. M. Kinase RIP3 is dispensable for normal NF kappa Bs, signaling by the B cell and T cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4. Mol. Cell. Biol. 24, 1464-1469 (2004
152. Kaiser, W. J., et al. RIP3 mediates the embryonic lethality of caspase 8 deficient mice. Nature 471, 368-372 (2011
153. Dillon, C. P., et al. Survival function of the FADD-CASPASE 8 cFLIP(L) complex. Cell Rep. 1, 401-407 (2012
154. Lawlor, K. E., et al. RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL. Nat. Commun. 6, 6282 (2015
155. Lattuada, D., et al. Proapoptotic activity of a monomeric smac mimetic on human fibroblast-like synoviocytes from patients with rheumatoid arthritis. Inflammation 38, 102-109 (2015
156. Deveraux, Q. L., et al. IAPs block apoptotic events induced by caspase 8 and cytochrome c by direct inhibition of distinct caspases. EMBO J. 17, 2215-2223 (1998
157. Du, C., Fang, M., Li, Y., Li, L., & Wang, X. Smac, a mitochondrial protein that promotes cytochrome c dependent caspase activation by eliminating IAP inhibition. Cell 102, 33-42 (2000
158. Verhagen, A. M., et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102, 43-53 (2000
159. Shin, Y. J., et al. Autophagy induction and CHOP under-expression promotes survival of fibroblasts from rheumatoid arthritis patients under endoplasmic reticulum stress. Arthritis Res. Ther. 12, R19 (2010
160. Xu, K., et al. Reduced apoptosis correlates with enhanced autophagy in synovial tissues of rheumatoid arthritis. Inflamm Res. 62, 229-237 (2013
161. Kato, M., Ospelt, C., Gay, R. E., Gay, S., & Klein, K. Dual role of autophagy in stress-induced cell death in rheumatoid arthritis synovial fibroblasts. Arthritis Rheumatol. 66, 40-48 (2014
162. Buckland, J. Rheumatoid arthritis: Autophagy: a dual role in the life and death of RASFs. Nat. Rev. Rheumatol 9, 637 (2013
163. Allan, L. A., & Clarke, P. R. Apoptosis and autophagy: Regulation of caspase 9 by phosphorylation. FEBS J. 276, 6063-6073 (2009
164. Cronstein, B. N. Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis. Pharmacol. Rev. 57, 163-172 (2005
165. Nakazawa, F., et al. Methotrexate inhibits rheumatoid synovitis by inducing apoptosis. J. Rheumatol 28, 1800-1808 (2001
166. Smith, M. D., et al. Apoptosis in the rheumatoid arthritis synovial membrane: modulation by disease-modifying anti-rheumatic drug treatment. Rheumatology (Oxford) 49, 862-875 (2010
167. Xu, K., et al. Autophagy induction contributes to the resistance to methotrexate treatment in rheumatoid arthritis fibroblast-like synovial cells through high mobility group box chromosomal protein 1. Arthritis Res. Ther. 17, 374 (2015
168. Yang, Z., Fujii, H., Mohan, S. V., Goronzy, J. J., & Weyand, C. M. Phosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cells. J. Exp. Med. 210, 2119-2134 (2013
169. Ireland, J. M., & Unanue, E. R. Autophagy in antigen-presenting cells results in presentation of citrullinated peptides to CD4 T cells. J. Exp. Med. 208, 2625-2632 (2011
170. Wegner, N., et al. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol. Rev. 233, 34-54 (2010
171. Lin, N. Y., et al. Autophagy regulates TNFalpha-mediated joint destruction in experimental arthritis. Ann. Rheum. Dis. 72, 761-768 (2013
172. Onuora, S. Bone research: Autophagy is central to joint destruction in arthritis. Nat. Rev. Rheumatol 8, 633 (2012
173. Yan, H., Zhou, H. F., Hu, Y., & Pham, C. T. Suppression of experimental arthritis through AMP-Activated protein kinase activation and autophagy modulation. J. Rheum. Dis. Treat. 1, 5 (2015
174. Orozco, G., et al. Study of the common genetic background for rheumatoid arthritis and systemic lupus erythematosus. Ann. Rheum. Dis. 70, 463-468 (2011
175. Hampe, J., et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet. 39, 207-211 (2007
176. Palomino-Morales, R. J., et al. Association of ATG16L1 and IRGM genes polymorphisms with inflammatory bowel disease: a meta-Analysis approach. Genes Immun. 10, 356-364 (2009
177. Lubberts, E., Koenders, M. I., & van den Berg, W. B. The role of T cell interleukin 17 in conducting destructive arthritis: lessons from animal models. Arthritis Res. Ther. 7, 29-37 (2005
178. Nakae, S., Nambu, A., Sudo, K., & Iwakura, Y. Suppression of immune induction of collagen-induced arthritis in IL 17 deficient mice. J. Immunol. 171, 6173-6177 (2003
179. Luross, J. A., & Williams, N. A. The genetic and immunopathological processes underlying collagen-induced arthritis. Immunology 103, 407-416 (2001
180. Wenink, M. H., Han, W., Toes, R. E., & Radstake, T. R. Dendritic cells and their potential implication in pathology and treatment of rheumatoid arthritis. Handb Exp. Pharmacol. 188, 81-98 (2009
181. Kelchtermans, H., et al. Effector mechanisms of interleukin 17 in collagen-induced arthritis in the absence of interferon-gamma and counteraction by interferon-gamma. Arthritis Res. Ther. 11, R122 (2009
182. Billiau, A., & Matthys, P. Collagen-induced arthritis and related animal models: how much of their pathogenesis is auto-immune, how much is auto-inflammatory? Cytokine Growth Factor Rev. 22, 339-344 (2011
183. Genovese, M. C., et al. Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study. Ann. Rheum. Dis. 72, 863-869 (2013
184. Matsumoto, I., Staub, A., Benoist, C., & Mathis, D. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 286, 1732-1735 (1999
185. Bevaart, L., Vervoordeldonk, M. J., & Tak, P. P. Evaluation of therapeutic targets in animal models of arthritis: how does it relate to rheumatoid arthritis? Arthritis Rheum. 62, 2192-2205 (2010
186. Ji, H., et al. Arthritis critically dependent on innate immune system players. Immunity 16, 157-168 (2002
187. Korganow, A. S., et al. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 10, 451-461 (1999
188. Maccioni, M., et al. Arthritogenic monoclonal antibodies from K/BxN mice. J. Exp. Med. 195, 1071-1077 (2002
189. Corr, M., & Crain, B. The role of FcγR signaling in the K/B x N serum transfer model of arthritis. J. Immunol. 169, 6604-6609 (2002
190. Ji, H., et al. Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis. J. Exp. Med. 196, 77-85 (2002
191. Manganelli, P., & Fietta, P. Apoptosis and Sjogren syndrome. Semin. Arthritis Rheum. 33, 49-65 (2003
192. Zhu, A., et al. Fas/FasL, Bcl2 and Caspase 8 gene polymorphisms in Chinese patients with rheumatoid arthritis. Rheumatol. Int. 36, 807-818 (2016
193. Anaya, J. M., Mantilla, R. D., & Correa, P. A. Immunogenetics of primary Sjogren?s syndrome in Colombians. Semin. Arthritis Rheum. 34, 735-743 (2005
194. Delgado-Vega, A. M., et al. Bcl 2 antagonist killer 1 (BAK1) polymorphisms influence the risk of developing autoimmune rheumatic diseases in women. Ann. Rheum. Dis. 69, 462-465 (2010
195. Kollek, M., Muller, A., Egle, A., & Erlacher, M. Bcl 2 proteins in development health and disease of the hematopoietic system. FEBS J. http://dx.doi.org/10.1111/febs.13683 2016
196. Ogilvy, S., et al. Constitutive Bcl 2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc. Natl Acad. Sci. USA 96, 14943-14948 (1999
197. Fang, W., et al. Frequent aberrant immunoglobulin gene rearrangements in pro B cells revealed by a Bcl xL transgene. Immunity 4, 291-299 (1996
198. Chao, D. T., & Korsmeyer, S. J. BCL XL regulated apoptosis in T cell development. Int. Immunol. 9, 1375-1384 (1997
199. Bonilla, D. L., et al. Autophagy regulates phagocytosis by modulating the expression of scavenger receptors. Immunity 39, 537-547 (2013